Human Genome Epidemiology Literature Finder
|
Records 1 - 18 (of 18 Records) |
| Query Trace: Hepatitis C and CYP27B1[original query] |
|---|
| Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. Journal of hepatology 2010 Dec . Lange CM, Bojunga J, Ramos-Lopez E, Wagner MV, Hassler A, Vermehren J, Herrmann E, Badenhoop K, Zeuzem S, Sarrazin C |
| Single-nucleotide polymorphism at CYP27B1-1260, but not VDR Taq I, is possibly associated with persistent hepatitis B virus infection. Genetic testing and molecular biomarkers 2012 Sep 16 (9): 1115-21. Zhu Qianqian, Li Na, Han Qunying, Li Zhu, Zhang Guoyu, Li Fang, Zhang Pingping, Chen Jinghong, Lv Yi, Liu Zhengw |
| A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. PloS one 2012 7 (7): e40159. Lange Christian M, Bibert Stephanie, Kutalik Zoltan, Burgisser Philippe, Cerny Andreas, Dufour Jean-Francois, Geier Andreas, Gerlach Tilman J, Heim Markus H, Malinverni Raffaele, Negro Francesco, Regenass Stephan, Badenhoop Klaus, Bojunga Jörg, Sarrazin Christoph, Zeuzem Stefan, Müller Tobias, Berg Thomas, Bochud Pierre-Yves, Moradpour Darius, |
| Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment. Therapeutic drug monitoring 2012 Dec 34 (6): 6. D?avolio A, Ciancio A, Siccardi M, Smedile A, Simiele M, Cusato J, Baietto L, Marucco DA, Cariti G, Calcagno A, Gonzalez de Requena D, Sciandra M, Troshina G, Caviglia GP, Bonora S, Rizzetto M, Di Perri G |
| Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon. Journal of viral hepatitis 2015 Mar 22 (3): 318-27. Boglione L, Cusato J, De Nicolò A, Cariti G, Di Perri G, D'Avolio |
| Vitamin D pathway gene variants and HCV-2/3 therapy outcomes. Antiviral therapy 2015 20 (3): 335-41. Cusato Jessica, Allegra Sarah, Boglione Lucio, De Nicolò Amedeo, Baietto Lorena, Cariti Giuseppe, Di Perri Giovanni, D'Avolio Anton |
| Vitamin D-related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C. Journal of medical virology 2015 Nov 87 (11): 1904-12. Arai Taeang, Atsukawa Masanori, Tsubota Akihito, Kondo Chisa, Shimada Noritomo, Abe Hiroshi, Itokawa Norio, Nakagawa Ai, Okubo Tomomi, Aizawa Yoshio, Iwakiri Katsuhi |
| Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia. Pharmacogenetics and genomics 2016 Jun 26 (6): 307-10. Cusato Jessica, Boglione Lucio, De Nicolò Amedeo, Cardellino Chiara Simona, Carcieri Chiara, Cariti Giuseppe, Di Perri Giovanni, D'Avolio Anton |
| Genetic Polymorphism of CYP27B1-1260 as Associated With Impaired Fasting Glucose in Patients With Chronic Hepatitis C Undergoing Antiviral Therapy. Hepatitis monthly 2016 Sep 16 (9): e35179. Sun Derong, Qi Wenqian, Wang Song, Wang Xu, Zhang Yonggui, Wang Jiangb |
| Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients. Pharmacogenomics 2017 Apr . Cusato Jessica, Boglione Lucio, De Nicolò Amedeo, Imbornone Rosaria, Cardellino Chiara Simona, Ghisetti Valeria, Carcieri Chiara, Cariti Giuseppe, Di Perri Giovanni, D'Avolio Anton |
| Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients. BMC gastroenterology 2017 Apr 17 (1): 54. Thanapirom Kessarin, Suksawatamnuay Sirinporn, Sukeepaisarnjaroen Wattana, Tangkijvanich Pisit, Treeprasertsuk Sombat, Thaimai Panarat, Wasitthankasem Rujipat, Poovorawan Yong, Komolmit Piyaw |
| Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study. PloS one 2017 12 (3): e0173263. Thanapirom Kessarin, Suksawatamnuay Sirinporn, Sukeepaisarnjareon Wattana, Tanwandee Tawesak, Charatcharoenwitthaya Phunchai, Thongsawat Satawat, Leerapun Apinya, Piratvisuth Teerha, Boonsirichan Rattana, Bunchorntavakul Chalermrat, Pattanasirigool Chaowalit, Pornthisarn Bubpha, Tantipanichtheerakul Supot, Sripariwuth Ekawee, Jeamsripong Woramon, Sanpajit Teeranan, Poovorawan Yong, Komolmit Piyaw |
| Association of vitamin-D-related genetic variations and treatment response to pegylated interferon in patients with chronic hepatitis B. Antiviral therapy 2017 Mar . Limothai Umaporn, Chuaypen Natthaya, Khlaiphuengsin Apichaya, Chittmittraprap Salyavit, Poovorawan Yong, Tangkijvanich Pis |
| Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. Cancer chemotherapy and pharmacology 2018 Jan . Cusato Jessica, Boglione Lucio, De Nicolò Amedeo, Favata Fabio, Ariaudo Alessandra, Mornese Pinna Simone, Guido Federica, Avataneo Valeria, Cantù Marco, Carcieri Chiara, Cariti Giuseppe, Di Perri Giovanni, D'Avolio Anton |
| Impact of CYP2R1, CYP27A1 and CYP27B1 genetic polymorphisms controlling vitamin D metabolism on susceptibility to hepatitis C virus infection in a high-risk Chinese population. Archives of virology 2019 Sep . Yang Jing-Jing, Fan Hao-Zhi, Tian Ting, Wu Meng-Ping, Xie Chao-Nan, Huang Peng, Yu Rong-Bin, Yi Hong-Gang, Zhang Yun, Wang J |
| Vitamin D-Binding protein Gene Polymorphism Predicts
Pegylated Interferon-Related HBsAg Seroclearance in
HBeAg-Negative Thai Chronic Hepatitis B Patients: A
Multicentre Study Asian Pacific journal of cancer prevention : APJCP 2019 Apr 20 (4): 1257-1264. Thanapirom Kessarin, Suksawatamnuay Sirinporn, Sukeepaisarnjaroen Wattana, Treeprasertsuk Sombat, Tanwandee Tawesak, Charatcharoenwitthaya Phunchai, Thongsawat Satawat, Leerapun Apinya, Piratvisuth Teerha, Boonsirichan Rattana, Bunchorntavakul Chalermrat, Pattanasirigool Chaowalit, Pornthisarn Bubpha, Tuntipanichteerakul Supot, Sripariwuth Ekawee, Jeamsripong Woramon, Sanpajit Theeranan, Poovorawan Yong, Komolmit Piyaw |
| Genetic variations in the CXCR5 gene decrease the risk of clinical relapse after discontinuation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2019 Nov 78 104124. Wu Yin, Fan Jiaojiao, Liao Guichan, Xia Muye, Jiang Deke, Peng Jie, Zhang Xiaoyong, Liu Hongy |
| Prediction Model for the Clearance of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B before Interferon Therapy: A Prospective Case-Control Study. Diagnostics (Basel, Switzerland) 2024 1 14 (1): . Nan Geng, Lina Ma, Yi Jin, Junfeng Lu, Yanhong Zheng, Junli Wang, Xiaoxiao Wang, Xinyue Ch |
- Page last reviewed:Feb 1, 2024
- Content source: